Showing results (761-770 of 816) with videos related to
Sort By:
Pageof 82
Bone Marrow Transplantation|April 21, 2009
Therapy with mycophenolate mofetil for refractory acute and chronic GVHDT Furlong, P Martin, M E D Flowers, et al.Bone Marrow Transplantation|May 4, 2004
Analysis of 96 patients with advanced ovarian carcinoma treated with high-dose chemotherapy and autologous stem cell transplantationM L Donato, A Aleman, R E Champlin, et al.Blood|May 15, 1997
Cyclosporine or cyclosporine plus methylprednisolone for prophylaxis of graft-versus-host disease: a prospective, randomized trialH J Deeg, D Lin, W Leisenring, et al.Blood|September 9, 2000
Phase 3 study comparing methotrexate and tacrolimus with methotrexate and cyclosporine for prophylaxis of acute graft-versus-host disease after marrow transplantation from unrelated donorsR A Nash, J H Antin, C Karanes, et al.Blood|July 10, 1998
Association between pretransplant interferon-alpha and outcome after unrelated donor marrow transplantation for chronic myelogenous leukemia in chronic phaseA J Morton, T Gooley, J A Hansen, et al.The New England Journal of Medicine|February 10, 1983
Graft-versus-host disease and survival in patients with aplastic anemia treated by marrow grafts from HLA-identical siblings. Beneficial effect of a protective environmentR Storb, R L Prentice, C D Buckner, et al.Bone Marrow Transplantation|August 24, 2004
Second transplant for acute and chronic leukemia relapsing after first HLA-identical sibling transplantM Eapen, S A Giralt, M M Horowitz, et al.Current Eye Research|March 1, 1997
Quasielastic light scattering study of the living human lens as a function of ageG M Thurston, D L Hayden, P Burrows, et al.Blood|June 1, 1997
Transplantation of marrow cells from unrelated donors for treatment of high-risk acute leukemia: the effect of leukemic burden, donor HLA-matching, and marrow cell doseJ Sierra, B Storer, J A Hansen, et al.Blood|August 1, 1996
Evaluation of a CD5-specific immunotoxin for treatment of acute graft-versus-host disease after allogeneic marrow transplantationP J Martin, B J Nelson, F R Appelbaum, et al.Pageof 82